Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQ3SAY)

Drug Name
CGNLSTCBLGTYTQDF[DKFHO]YPQTAIGVGAP-amide Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
73352989
TTD Drug ID
DMQ3SAY

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Calcitonin receptor (CALCR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitonin Human DM0N9WA Paget's disease FB85 Approved [2]
Salmon Calcitonin DMEWUPF Bone Paget disease Approved [3]
DACRA 089 DM5TB76 Type 2 diabetes 5A11 Phase 1 [4]
LY 3541105 DMJ1X85 Obesity 5B81 Phase 1 [5]
TJN-220 DM4YQDX Hypertension BA00-BA04 Terminated [6]
CSNLSTCVLGKLSQELc[DKLHK]YPRTNTGSGTP-amide DMYDTO8 Discovery agent N.A. Investigative [1]
CGNLSTCMLGTYTQDFNKPHTFPQTAIGVGAP-amide DME84PN Discovery agent N.A. Investigative [1]
CGNLSTCMLGTYTQDFc[DKFHK]FPQTAIGVGAP-amide DMUGAYT Discovery agent N.A. Investigative [1]
CSNLSTCVLGKLSQELc[DKLHO]YPRTNTGSGTP-amide DMQXEHJ Discovery agent N.A. Investigative [1]
CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-amide DMJ9Z31 Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcitonin receptor (CALCR) TTLWS2O CALCR_HUMAN Inhibitor [1]

References

1 Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept fo... J Med Chem. 2002 Feb 28;45(5):1108-21.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3 Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Peptides. 2009 Jul;30(7):1288-95.
4 A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. Br J Pharmacol. 2017 Apr;174(7):591-602.
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
6 Evaluation of the long-lasting antihypertensive action of 7-O-ethylfangchinoline. Jpn J Pharmacol. 1994 Sep;66(1):35-46.